Research on the treatment and prevention of these illnesses therefore belongs to one of the most important medical issues of the future. The Cologne Excellence Cluster CECAD Cologne (Cellular Stress Responses in Aging-Associated Diseases) made it its objective to gain a better understanding of the molecular mechanisms underlying lifespan regulation and aging-associated diseases in order to achieve its long-term objective of developing new therapeutic interventions.
The Cologne Excellence Cluster (CECAD Cologne), which will receive over six million euros annually within the framework of the Excellence Initiative, will bring together researchers and clinicians from the University of Cologne and the University Hospital with researchers from the new Max Planck Institute for Biology of Aging. This constellation makes the CECAD-Cologne the first ever research center in Europe to dedicate itself solely to discovering the underlying mechanisms of aging along with those triggering aging-associated diseases.
It is therefore envisioned that this cluster will become an internationally recognized leader at the forefront of aging research paving the way for the development of preventive and novel therapeutic interventions. "Cologne is the epicenter of an excellent regional health care service continually demonstrating outstanding competence in the areas of science and research,” said Cologne’s Lord Mayor Fritz Schramma, who started the initiative "Health Cologne" in association with the University of Cologne and other health care authorities last year. Lord Mayor Schramma also said, "With the Excellence Cluster CECAD-Cologne, Cologne’s health care will become a leading center in the domain of "Gesundheit für Generationen (Health for the Generations)”, which is increasingly important for future development – not only for Cologne.”
The University Rector Prof. Dr. Axel Freimuth also pointed out: “Through CECAD-Cologne, we have yet another beacon in our profile domain of life sciences.” We hereby cordially invite you to the press conference on the occasion of the official presentation of the CECAD-Cologne.The following parties will be taking part in the press conference:
-Prof. Dr. Thomas Langer, Speaker for the Collaborative Research Center 635 (Posttranslational Control of Proteins).
Place: University of Cologne, Main Building, Alter Senatssaal
Time: 12:45-13:45, 7th February 2008
Patrick Honecker | alfa
New flexible, transparent, wearable biopatch, improves cellular observation, drug delivery
12.11.2018 | Purdue University
Exosomes 'swarm' to protect against bacteria inhaled through the nose
12.11.2018 | Massachusetts Eye and Ear Infirmary
Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.
In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...
On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.
When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure
Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...
Physicists at ETH Zurich demonstrate how errors that occur during the manipulation of quantum system can be monitored and corrected on the fly
The field of quantum computation has seen tremendous progress in recent years. Bit by bit, quantum devices start to challenge conventional computers, at least...
Scientists developed specially coated nanometer-sized vehicles that can be actively moved through dense tissue like the vitreous of the eye. So far, the transport of nano-vehicles has only been demonstrated in model systems or biological fluids, but not in real tissue. The work was published in the journal Science Advances and constitutes one step further towards nanorobots becoming minimally-invasive tools for precisely delivering medicine to where it is needed.
Researchers of the “Micro, Nano and Molecular Systems” Lab at the Max Planck Institute for Intelligent Systems in Stuttgart, together with an international...
09.11.2018 | Event News
06.11.2018 | Event News
23.10.2018 | Event News
12.11.2018 | Life Sciences
12.11.2018 | Materials Sciences
12.11.2018 | Physics and Astronomy